Please login to the form below

Not currently logged in
Email:
Password:

medicines

This page shows the latest medicines news and features for those working in and with pharma, biotech and healthcare.

MHRA approves second COVID-19 antibody treatment

MHRA approves second COVID-19 antibody treatment

The UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), has approved a second antibody treatment against COVID-19.

Latest news

More from news
Approximately 197 fully matching, plus 4,216 partially matching documents found.

Latest Intelligence

  • A new focus on patient-centricity through remote healthcare A new focus on patient-centricity through remote healthcare

    to deliver ‘at home initiation’ processes for new medicines. ... Another example is enabling patients to have access to medicines at home during lockdown, that would otherwise have been denied, and ensuring that those patients are set up and

  • Building the perfect behaviour-change buffet Building the perfect behaviour-change buffet

    lives. To encourage people to take the medicines they need, or switch to a healthier lifestyle, we must first implement some behavioural psychology. ... Ideally you do this up front, through individualised medicine. But when that’s not available, put

  • Solving healthcare problems Solving healthcare problems

    We have seen the rapid development of and access to vaccines and medicines and government-led behavioural change programmes. ... In turn, this has sparked broad debate around the possibilities afforded by rapidly developing medicines and vaccines, the

  • All change – how untangling human behaviour can encourage better health All change – how untangling human behaviour can encourage better health

    Every company should be looking at changing behaviours because that is how they will get their products, their medicines, to the right people at the right time.

  • Health For All Health For All

    and more human; Professor Eleanor Stride spoke to us about how a more inclusive drug development process can bring new medicines to market more quickly, Dr Christine Ekechi provided insight into

More from intelligence
Approximately 27 fully matching, plus 622 partially matching documents found.

Latest appointments

More from appointments
Approximately 10 fully matching, plus 364 partially matching documents found.

Latest from PMHub

  • Cancer: Beyond the Backlog Cancer: Beyond the Backlog

    The pandemic also allowed for innovation in access to cancer medicines, with a £160 million initiative launched in August 2020 to fund drugs that treat patients without having such a big

  • Committing time to making meaningful connections - top 5 tips Committing time to making meaningful connections - top 5 tips

    Barrier 2: Committing time to making meaningful connections. Connecting with a wide range of relevant people to inform and guide research and medicine development is one of the most important steps

  • emotive supports Rare Disease Day 2019

    On 20th  February, we attended ‘The Unusual Suspects: Rare Diseases in Everyday Medical Care” at the Royal Society of Medicine, hosted by Medics 4 Rare Diseases (M4RD).  . ... work we do in such an innovative area of medicine.   .

  • Mednet Group’s growth spurt

    ve settled in quickly with the team being so friendly and I’m looking forward to getting involved in a range of projects in the field of healthcare and medicine.”.

  • The 7 biggest risks to e-detailing success

    E-detailers promote medicines to healthcare professionals (HCPs) over the phone and via online platforms, such as WebEx.

More from PMHub
Approximately 53 fully matching, plus 372 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
integrated medhealth communication

imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...